1. Scrip
  3. >>Alimentary/Metabolic

Novo Nordisk adds DKK30 million settlement to alleged kickback payouts

 
• By Becky Debens

Settlements to end Novo Nordisk's involvement in the UN oil-for-food programme kickback casel have spread into Europe, with the company issuing a payout of DKK30 million ($5.6 million) to Danish authorities.

Settlements to end Novo Nordisk's involvement in the UN oil-for-food programme kickback casel have spread into Europe, with the company issuing a payout of DKK30 million ($5.6 million) to Danish authorities.

The company reached the settlement with the Danish Public Prosecutor for Serious Economic Crime, the specialised unit of the Danish Prosecution Service

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Alimentary/Metabolic

More from Therapeutic Category

In Brief: Positive New Data For Aptose’s Triplet Therapy In 1L AML

 
• By Sushmita Panda

Aptose’s tuspetinib triplet shows early mutation-agnostic promise in new data from Phase I/II program for frontline acute myeloid leukemia.

Chinese Firms Build Obesity Clinical Pipeline But Face Wider Hurdles

 
• By Xu Hu

Despite the ability to initiate clinical trials quickly and having strong manufacturing capacity, Chinese companies are facing multiple challenges in the obesity space.

Aldeyra Plans To File Reproxalap Again With New Dry Eye Symptom Data

 
• By Joseph Haas

The biotech hopes a third time will be the charm after two FDA complete responses, with plans to position its eye drop as offering quicker onset of action.